Stay updated with breaking news from Daniel Janney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its target price upped by Chardan Capital from $133.00 to $148.00 in a research note issued to investors on Monday morning, The Fly reports. Other equities analysts have also recently issued research reports about the stock. William Blair reaffirmed an outperform rating on shares of Krystal Biotech in […]
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its target price boosted by Guggenheim from $101.00 to $130.00 in a report issued on Monday, The Fly reports. Guggenheim’s price target indicates a potential upside of 9.12% from the stock’s current price. Other equities analysts also recently issued research reports about the stock. Stifel Nicolaus began coverage […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) Director Daniel Janney sold 50,000 shares of Krystal Biotech stock in a transaction on Friday, May 19th. The stock was sold at an average price of $95.02, for a total transaction of $4,751,000.00. Following the sale, the director now directly owns 157,362 shares in the company, valued at […]
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) have earned a consensus rating of “Buy” from the six brokerages that are presently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued ratings on the stock in the […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating)’s stock price reached a new 52-week high during trading on Friday . The company traded as high as $94.61 and last traded at $93.64, with a volume of 774086 shares. The stock had previously closed at $87.45. Analyst Ratings Changes A number of equities research analysts have issued […]